Merontos, Menzl Mae V.
HRN: 13 21 16 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
CEFUROXIME 500MG (TAB)
05/28/2023
06/03/2023
PI
500mg
BID
Uti
Checking Final Appropriateness
05/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/28/2023
06/04/2023
IV
500mg
Q8
Amoebiasis
Checking Final Appropriateness